Early clinical experience with a newly formulated hydroxyethyl starch--Hextend.
Woolf
R L
RL
Chapman
M V
MV
Mythen
M G
MG
D006438:Hemodilution / Q000379:methods*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*; D010952:Plasma Substitutes / Q000627:therapeutic use*
D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes